Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer

D. S. Alberts, M. Markman, F. Muggia, R. F. Ozols, E. Eldermire, M. A. Bookman, T. Chen, J. Curtin, L. M. Hess, L. Liebes, R. C. Young, E. Trimble

Research output: Contribution to journalReview article

28 Scopus citations

Abstract

Ovarian cancer is the leading cause of gynecologic cancer deaths in the U.S. The concept of intraperitoneal drug delivery for therapy of intraperitoneal cancers, such as ovarian cancer, arose in the 1960s. The field of intraperitoneal cisplatin therapy for ovarian cancer was initiated in the late 1970s and early 1980s. The markedly improved survival data resulting from a phase III trial of intraperitoneal cisplatin for ovarian cancer in early 2006 led to an NCI Clinical Announcement and a Gynecologic Oncology Group-sponsored workshop on intraperitoneal therapy in January, 2006, in San Diego, California. The proceedings of this workshop summarize both research trial results and practical implementation issues associated with intraperitoneal therapy discussed at this workshop.

Original languageEnglish (US)
Pages (from-to)783-792
Number of pages10
JournalGynecologic oncology
Volume103
Issue number3
DOIs
StatePublished - Dec 1 2006

Keywords

  • Intraperitoneal chemotherapy
  • Oncology
  • Ovarian cancer

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer'. Together they form a unique fingerprint.

  • Cite this

    Alberts, D. S., Markman, M., Muggia, F., Ozols, R. F., Eldermire, E., Bookman, M. A., Chen, T., Curtin, J., Hess, L. M., Liebes, L., Young, R. C., & Trimble, E. (2006). Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer. Gynecologic oncology, 103(3), 783-792. https://doi.org/10.1016/j.ygyno.2006.09.012